Actively Recruiting
Screening for Chronic Liver Diseases in General Population
Led by University Hospital, Montpellier · Updated on 2025-07-10
260
Participants Needed
1
Research Sites
224 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Montpellier
Lead Sponsor
O
On-call medical home (MMG) Clermont-Hérault
Collaborating Sponsor
AI-Summary
What this Trial Is About
Improving the care of patients with liver diseases in primary care and will allow patients with chronic liver disease to benefit from a course appropriate care.
CONDITIONS
Official Title
Screening for Chronic Liver Diseases in General Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 40 years or older
- No known liver diseases
- At least one risk factor for chronic liver disease such as risky alcohol consumption, metabolic syndrome, diabetes, or risk for viral hepatitis B, D, or C
You will not qualify if you...
- Fibroscan performed within the last 12 months
- Unable to give express oral consent
- Not affiliated with or not covered by national health insurance
- Legally protected patient
- Under guardianship or curatorship
- Deprived of liberty
- Pregnant or breastfeeding woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier
Montpellier, France, 34295
Actively Recruiting
Research Team
M
Magdalena MESZAROS, MD
CONTACT
C
Corinne ROTROU, CRA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here